volume 16, issue 12, P1229-1235 1997
DOI: 10.1076/ceyr.16.12.1229.5035
View full text
|
|
Share

Abstract: These studies demonstrated that, in spite of marked reduction in serum cholesterol, atorvastatin was not cataractogenic in dogs at any tested dose. We conclude that atorvastatin differs from other RIs in this regard.